Literature DB >> 4311250

A nondefective (competent) adenovirus-SV40 hybrid isolated from the AD.2-SV40 hybrid population.

A M Lewis, M J Levin, W H Wiese, C S Crumpacker, P H Henry.   

Abstract

A new nondefective hybrid virus has been plaque-isolated from the Ad.2-SV40 hybrid population. This virus replicates efficiently with one-hit kinetics in both human embryonic kidney and African green monkey kidney cells, induces an SV40 specific antigen which is detectable by immunofluorescence and complement-fixation using sera from SV40 tumor-bearing hamsters, and produces SV40-specific RNA detectable by DNA-RNA hybridization. The SV40-specific antigen induced by this virus is heat-stable, sensitive to inhibitors of DNA synthesis, serologically different from SV40 T and viral antigens, and is an unrecognized SV40 antigen.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4311250      PMCID: PMC223439          DOI: 10.1073/pnas.63.4.1128

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  THE PURIFICATION OF SIMIAN VIRUS 40.

Authors:  P H BLACK; E M CRAWFORD; L V CRAWFORD
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

2.  INDUCTION BY ADENOVIRUS TYPE 7 OF TUMORS IN HAMSTERS HAVING THE ANTIGENIC CHARACTERISTICS OF SV40 VIRUS.

Authors:  R J HUEBNER; R M CHANOCK; B A RUBIN; M J CASEY
Journal:  Proc Natl Acad Sci U S A       Date:  1964-12       Impact factor: 11.205

3.  THE INCORPORATION OF SV40 MATERIAL INTO ADENOVIRUS 7 AS MEASURED BY INTRANUCLEAR SYNTHESIS OF SV40 TUMOR ANTIGEN.

Authors:  F RAPP; J L MELNICK; J S BUTEL; T KITAHARA
Journal:  Proc Natl Acad Sci U S A       Date:  1964-12       Impact factor: 11.205

4.  VIRAL STUDIES OF SV40 TUMORIGENESIS IN HAMSTERS.

Authors:  P H BLACK; W P ROWE
Journal:  J Natl Cancer Inst       Date:  1964-01       Impact factor: 13.506

5.  The presence of antibodies in human serum to early (T) adenovirus antigens.

Authors:  A M Lewis; W H Wiese; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1967-03       Impact factor: 11.205

6.  Virus-specific nucleic acids in SV40-exposed hamster embryo cell lines: correlation with S and T antigens.

Authors:  M J Levin; M N Oxman; G T Diamandopoulos; A S Levine; P H Henry; J F Enders
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

7.  Studies of adenovirus-SV40 hybrid viruses, VI. Differential effects of interferon on SV40 and adenovirus T antigen formation in cells infected with SV40 virus, adenoviruses, and adenovirus-SV40 hybrid viruses.

Authors:  M N Oxman; W P Rowe; P H Black
Journal:  Proc Natl Acad Sci U S A       Date:  1967-04       Impact factor: 11.205

8.  Interrelationship of adenovirus (type 4) and papovavirus (SV-40) in monkey kidney cell cultures.

Authors:  W B Beardmore; M J Havlick; A Serafini; I W McLean
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

9.  Occurrence of adenovirus-SV40 hybrids among monkey kidney cell adapted strains of adenovirus.

Authors:  A M Lewis; S G Baum; K O Prigge; W P Rowe
Journal:  Proc Soc Exp Biol Med       Date:  1966-05

10.  Studies of adenovirus-SV40 hybrid viruses. IV. An adenovirus type 2 strain carrying the infectious SV40 genome.

Authors:  A M Lewis; K O Prigge; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1966-03       Impact factor: 11.205

View more
  67 in total

1.  Characterization of a variant of human adenovirus type 2 which multiples efficiently in simian cells.

Authors:  D F Klessig; J A Hassell
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

2.  Characterization of an adenovirus early protein required for viral DNA replication: a single strand specific DNA binding proteins.

Authors:  A J Levine; P C van der Vliet; B Rosenwirth; C Anderson; J Rabek; A Levinson; S Anderson
Journal:  Mol Cell Biochem       Date:  1976-04-28       Impact factor: 3.396

3.  Squirrel monkeys support replication of BK virus more efficiently than simian virus 40: an animal model for human BK virus infection.

Authors:  Concepcion Zaragoza; Rui-Mei Li; Gary A Fahle; Steven H Fischer; Mark Raffeld; Andrew M Lewis; Jeffrey B Kopp
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Adenovirus transcription. II. RNA sequences complementary to simian virus 40 and adenovirus 2DNA in AD2+ND1- and AD2+ND3-infected cells.

Authors:  S J Flint; Y Wewerka-Lutz; A S Levine; J Sambrook; P A Sharp
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

5.  Biosynthesis, immunological specificity, and intracellular distribution of the simian virus 40-specific protein induced by the nondefective hybrid Ad2+ND1.

Authors:  G Jay; F T Jay; R M Friedman; A S Levine
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

6.  Synthesis of the Ad2+ND5-specified 42K protein is regulated posttranscriptionally in abortively infected monkey cells.

Authors:  L Silverman; K P Anderson; D F Klessig
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

7.  Partial block to transcription of human adenovirus type 2 late genes in abortively infected monkey cells.

Authors:  J M Johnston; K P Anderson; D F Klessig
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

8.  Evidence for a transcription-control region of Simian virus 40 in the adenovirus 2--Simian virus 40 hybrid, Ad2+ND 1 .

Authors:  C T Patch; A M Lewis; A S Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

9.  Efficient coupled transcription and mRNA splicing in vitro using plasmids derived from early region 3 of adenovirus 2 and a nondefective adenovirus-simian virus 40 hybrid.

Authors:  S Pawar; C M Ahmed; R Watkins; S Zain
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

10.  Simian virus to (SV40) tumor-specific proteins in nucleus and plasma membrane of HeLa cells infected by adenovirus 2-SV40 hybrid virus Ad2+ND2.

Authors:  W Deppert; G Walter
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.